Survival associated with two sets of diagnostic criteria for congestive heart failure

Gina D Schellenbaum1, Thomas D Rea, Susan R Heckbert

  • 1Department of Epidemiology, Cardiovascular Health Research Unit, University of Washington, Seattle, WA, USA. ginas@u.washington.edu

Insights

Congestive heart failure (CHF) definitions vary. This study found similar survival rates for CHF patients identified by Framingham criteria alone, Cardiovascular Health Study criteria alone, or both, indicating comparable mortality across diagnostic groups.

Area of Science:

  • Cardiology
  • Epidemiology
  • Gerontology

Background:

  • Congestive heart failure (CHF) definitions differ across epidemiologic studies.
  • The Framingham Heart Study (FHS) and Cardiovascular Health Study (CHS) use distinct criteria for CHF diagnosis.
  • Varied definitions can impact the understanding of CHF incidence and survival.

Purpose of the Study:

  • To compare CHF incidence and survival patterns using FHS and CHS diagnostic criteria.
  • To analyze survival differences between patients meeting both criteria, only FHS criteria, or only CHS criteria.

Main Methods:

  • Utilized data from the Cardiovascular Health Study, a cohort of 5,888 elderly US adults.
  • Constructed an inception cohort of 875 hospitalized CHF patients between 1989 and 2000.
  • Compared diagnostic classifications: concordant (both criteria), FHS-only, and CHS-only.

Main Results:

  • 54% of CHF events met both FHS and CHS criteria (concordant).
  • 31% met only FHS criteria, and 15% met only CHS criteria.
  • No significant survival differences were observed between FHS-only, CHS-only, and concordant groups.

Conclusions:

  • Framingham criteria identify more incident CHF cases than CHS criteria alone.
  • All-cause mortality rates were similar across different CHF diagnostic classifications.
  • CHF diagnostic criteria variations do not appear to significantly impact survival outcomes in this elderly cohort.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...